NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 09 04:00PM ET
25.93
Dollar change
+0.36
Percentage change
1.43
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-3.62% Total Holdings24 Perf Week2.60%
SponsorRoundhill Financial ETF Type Tagsequity Return% 3Y- AUM33.69M Perf Month-0.06%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter24.45%
Index- Average Maturity Tagspharmaceutical Return% 10Y 52W High29.21 -11.21% Perf Half Y5.60%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.01 29.61% Perf YTD6.46%
Active/Passive Quant Type Tags- Flows% 1M-9.53% Volatility1.84% 1.58% Perf Year-4.37%
Dividend TTM0.05 (0.20%) ESG Type Tags- Flows% 3M-12.83% ATR (14)0.48 Perf 3Y-
Dividend Ex-DateDec 30, 2024 Dividend Type Sector/Theme Flows% YTD-18.87% RSI (14)54.83 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.48 Perf 10Y-
Expense0.59% Growth/Value SMA20-0.18% Flows% 3Y Rel Volume0.71 Prev Close25.57
Inverse/Leveraged Market Cap SMA503.20% Flows% 5Y Avg Volume10.69K Price25.93
IPOMay 21, 2024 Option/ShortYes / Yes SMA2002.01% Trades Volume7,559 Change1.43%
Roundhill Glp-1 & Weight Loss ETF seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.